التفاصيل البيبلوغرافية
| العنوان: |
CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine. |
| المؤلفون: |
Capi, Matilde, De Angelis, Valerio, De Bernardini, Donatella, De Luca, Ottavia, Cipolla, Fabiola, Lionetto, Luana, Simmaco, Maurizio, Martelletti, Paolo, Andreou, Anna P., Wijeratne, Tissa |
| المصدر: |
Journal of Clinical Medicine; Apr2021, Vol. 10 Issue 7, p1429, 1p |
| مصطلحات موضوعية: |
CLINICAL trial registries, MIGRAINE, DRUG utilization, SMALL molecules |
| مستخلص: |
Discovering that calcitonin-related peptide (CGRP) plays a key role in the complex pathophysiology of migraine has allowed us to make great strides in the development of new approaches for acute and preventive treatment. This evidence has led to the development of small molecules antagonist molecules of the CGRP receptor ("gepants") and of a new class of medications called "Ditans". This review presents the data from clinical trials reporting the efficacy, safety, and tolerability of the new drugs used in the treatment of migraines. Evidences show that therapeutic approaches targeted to CGRP have the potential to transform the clinical management of migraine, even though its appropriate place has yet to be determined with accuracy. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder